Literature DB >> 10510743

Pharmacokinetics of fluconazole in young infants.

M C Nahata1, K B Tallian, R W Force.   

Abstract

Intravenous fluconazole is used in the treatment of fungal infections in infants. Little is known, however, about the pharmacokinetics of fluconazole after oral administration in premature infants. Oral fluconazole was administered at a dose of 6 mg/kg. The peak serum concentration (Cmax), area under the serum concentration-time curve (AUC), and apparent clearance ranged from 6.0-13.5 micrograms/ml, 340-636 micrograms.h/ml, and 0.16-0.29 ml/min/kg, respectively. The Cmax and AUC were comparable after oral and intravenous doses of fluconazole. Oral fluconazole was well absorbed and tolerated. The use of oral fluconazole may offer an important alternative to the intravenous therapy; it may improve patient convenience, reduce the need for venous access and decrease complications and the cost of health care.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510743     DOI: 10.1007/BF03190361

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  5 in total

1.  The disposition and metabolism of [14C]fluconazole in humans.

Authors:  K W Brammer; A J Coakley; S G Jezequel; M H Tarbit
Journal:  Drug Metab Dispos       Date:  1991 Jul-Aug       Impact factor: 3.922

2.  Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life.

Authors:  H Saxén; K Hoppu; M Pohjavuori
Journal:  Clin Pharmacol Ther       Date:  1993-09       Impact factor: 6.875

3.  Fluconazole in the treatment of candidiasis in immunocompromised children.

Authors:  C Viscoli; E Castagnola; F Fioredda; B Ciravegna; G Barigione; A Terragna
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

4.  Candida albicans septicemia in a premature infant successfully treated with oral fluconazole.

Authors:  S Bodé; L Pedersen-Bjergaard; K Hjelt
Journal:  Scand J Infect Dis       Date:  1992

5.  Pharmacokinetics of fluconazole in pediatric patients.

Authors:  K W Brammer; P E Coates
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-04       Impact factor: 3.267

  5 in total
  9 in total

Review 1.  Fluconazole pharmacokinetics and safety in premature infants.

Authors:  K Turner; P Manzoni; D K Benjamin; M Cohen-Wolkowiez; P B Smith; M M Laughon
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 2.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

3.  Pharmacokinetics of an elevated dosage of micafungin in premature neonates.

Authors:  P Brian Smith; Thomas J Walsh; William Hope; Antonio Arrieta; Akitsugu Takada; Laura L Kovanda; Gregory L Kearns; David Kaufman; Taiji Sawamoto; Donald N Buell; Daniel K Benjamin
Journal:  Pediatr Infect Dis J       Date:  2009-05       Impact factor: 2.129

Review 4.  The use of antifungal therapy in neonatal intensive care.

Authors:  Daniela Testoni; P Brian Smith; Daniel K Benjamin
Journal:  Clin Perinatol       Date:  2012-01-11       Impact factor: 2.642

5.  Population Pharmacokinetics of Fluconazole in Premature Infants with Birth Weights Less than 750 Grams.

Authors:  Jeremiah D Momper; Edmund V Capparelli; Kelly C Wade; Anand Kantak; Ramasubbareddy Dhanireddy; James J Cummings; Jonathan H Nedrelow; Mark L Hudak; Gratias T Mundakel; Girija Natarajan; Jamie Gao; Matt Laughon; P Brian Smith; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.938

Review 6.  Review of Fluconazole Treatment and Prophylaxis for Invasive Candidiasis in Neonates.

Authors:  Chi D Hornik; Deborah S Bondi; Nicole M Greene; M Petrea Cober; Barnabas John
Journal:  J Pediatr Pharmacol Ther       Date:  2021-02-15

7.  Potency and Preclinical Evidence of Synergy of Oral Azole Drugs and Miltefosine in an Ex Vivo Model of Leishmania (Viannia) panamensis Infection.

Authors:  Olga Lucía Fernández; Mariana Rosales-Chilama; Natali Quintero; Bruno L Travi; Dawn M Wetzel; María Adelaida Gómez; Nancy Gore Saravia
Journal:  Antimicrob Agents Chemother       Date:  2021-10-25       Impact factor: 5.938

8.  Developmental changes of fluconazole clearance in neonates and infants in relation to ontogeny of glomerular filtration rate: literature review and data analysis.

Authors:  Kazutoshi Murakoso; Ryoichi Minagawa; Hirotoshi Echizen
Journal:  J Pharm Health Care Sci       Date:  2018-03-20

Review 9.  Clinical Pharmacokinetics of Triazoles in Pediatric Patients.

Authors:  Didi Bury; Wim J E Tissing; Eline W Muilwijk; Tom F W Wolfs; Roger J Brüggemann
Journal:  Clin Pharmacokinet       Date:  2021-05-18       Impact factor: 5.577

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.